Oramed Pharmaceuticals Inc. (ORMP) has 20 已知的内部人和机构持有人记录. 最大持有人为 Lee James G 持有 10,069,013 股. 其他重要持有人包括 Bronfeld Zeev 和 KIDRON NADAV.
过去12个月，内部人进行了 25 笔交易，涉及 ORMP 股票 — 17 笔买入 (价值为 $1.44K) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
ORMP 內部人持股
最大持股人
Lee James G
10,069,013 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Lee James G |
CEO |
10,069,013 |
2004-06-03 |
|
| 2 |
Bronfeld Zeev |
10 Percent Owner |
5,808,517 |
2011-10-05 |
|
| 3 |
Kidron Nadav |
President and CEO |
3,422,243 |
2026-03-31 |
|
| 4 |
Hexter Joshua |
COO & Cbo |
1,160,384 |
2026-03-18 |
|
| 5 |
Kidron Miriam |
Chief Scientific Officer |
1,133,138 |
2026-03-31 |
|
| 6 |
Orlev Chaime |
CFO, Treasurer and Secretary |
828,000 |
2008-10-16 |
|
| 7 |
Gabay Avraham |
Chief Financial Officer |
745,145 |
2026-03-18 |
|
| 8 |
Silberman David |
Chief Financial Officer |
366,500 |
2024-01-08 |
|
| 9 |
Li Xiaopeng |
Director |
206,350 |
2017-08-03 |
|
| 10 |
Mayer Arie |
Director |
163,109 |
2026-01-05 |
|
| 11 |
Derovan Netanel |
Chief Legal Officer |
149,500 |
2023-05-31 |
|
| 12 |
Rozov Yadin |
Director |
146,500 |
2024-01-08 |
|
| 13 |
Sank Leonard |
Director |
128,021 |
2025-06-09 |
|
| 14 |
Rabinowitz Michael |
Chief Commercial Officer |
126,143 |
2023-01-04 |
|
| 15 |
Shapiro Benjamin |
Director |
119,720 |
2026-01-05 |
|
| 16 |
Aghion Daniel |
Director |
107,191 |
2026-01-02 |
|
| 17 |
Reznick Yehuda |
Director |
98,930 |
2026-01-05 |
|
| 18 |
Rakin Kevin |
Director |
46,661 |
2022-03-22 |
|
| 19 |
Law Ronald Edward |
Chief Strategy Officer |
37,152 |
2017-03-21 |
|
| 20 |
Eisenberg Hilla |
CFO, Treasurer and Secretary |
37,000 |
2019-02-28 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-30 |
Kidron Miriam |
Chief Scientific Officer |
RSU 预扣税 |
435,084 |
$3.31 |
$1.44M |
| 2026-03-30 |
Kidron Nadav |
President and CEO |
RSU 预扣税 |
44,818 |
$3.31 |
$148.35K |
| 2026-03-17 |
Gabay Avraham |
Chief Financial Officer |
限制性股票授予 (RSU) |
95,889 |
- |
- |
| 2026-03-17 |
Hexter Joshua |
COO & Cbo |
限制性股票授予 (RSU) |
95,889 |
- |
- |
| 2026-03-17 |
Kidron Miriam |
Chief Scientific Officer |
限制性股票授予 (RSU) |
119,558 |
- |
- |
| 2026-03-17 |
Kidron Nadav |
President and CEO |
限制性股票授予 (RSU) |
167,005 |
- |
- |
| 2026-03-12 |
Kidron Nadav |
President and CEO |
赠与（送出） |
100,000 |
- |
- |
| 2026-01-22 |
Gabay Avraham |
Chief Financial Officer |
期权行权（卖出） |
19,000 |
- |
- |
| 2026-01-22 |
Hexter Joshua |
COO & Cbo |
期权行权（卖出） |
19,000 |
- |
- |
| 2026-01-22 |
Kidron Miriam |
Chief Scientific Officer |
期权行权（卖出） |
19,000 |
- |
- |
| 2026-01-22 |
Kidron Nadav |
President and CEO |
期权行权（卖出） |
109,000 |
- |
- |
| 2026-01-14 |
Kidron Miriam |
Chief Scientific Officer |
赠与（送出） |
86,166 |
- |
- |
| 2025-12-31 |
Reznick Yehuda |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Shapiro Benjamin |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Mayer Arie |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Hexter Joshua |
COO & Cbo |
限制性股票授予 (RSU) |
19,000 |
- |
- |
| 2025-12-31 |
Kidron Miriam |
Chief Scientific Officer |
限制性股票授予 (RSU) |
19,000 |
- |
- |
| 2025-12-31 |
Kidron Nadav |
President and CEO |
限制性股票授予 (RSU) |
109,000 |
- |
- |
| 2025-12-31 |
Aghion Daniel |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Gabay Avraham |
Chief Financial Officer |
限制性股票授予 (RSU) |
19,000 |
- |
- |
| 2025-06-05 |
Reznick Yehuda |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
| 2025-06-05 |
Aghion Daniel |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
| 2025-06-05 |
Shapiro Benjamin |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
| 2025-06-05 |
Mayer Arie |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
| 2025-06-05 |
Sank Leonard |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
